BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32011508)

  • 1. Incomplete recovery from rocuronium-induced muscle relaxation in patients with amyotrophic lateral sclerosis using sugammadex: A case report.
    Chun HR; Chung J; Kim NS; Kim AJ; Kim S; Kang KS
    Medicine (Baltimore); 2020 Jan; 99(3):e18867. PubMed ID: 32011508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of sugammadex in a patient with amyotrophic lateral sclerosis.
    Kelsaka E; Karakaya D; Zengin EC
    Med Princ Pract; 2013; 22(3):304-6. PubMed ID: 23075763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficiency of the TOF-Cuff™ for the evaluation of rocuronium-induced neuromuscular block and its reversal with sugammadex: a comparative study vs. acceleromyography.
    Kameyama Y; Takagi S; Seto K; Kajiwara I; Goto M; Kitajima O; Suzuki T
    J Anesth; 2019 Feb; 33(1):80-84. PubMed ID: 30474732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rocuronium-induced neuromuscular block and sugammadex in pediatric patient with duchenne muscular dystrophy: A case Report.
    Kim JE; Chun HR
    Medicine (Baltimore); 2017 Mar; 96(13):e6456. PubMed ID: 28353578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular Block in Patients Having Catheter-Based Neurointerventional Procedures: A Randomized Trial.
    Farag E; Rivas E; Bravo M; Hussain S; Argalious M; Khanna S; Seif J; Pu X; Mao G; Bain M; Elgabaly M; Esa WAS; Sessler DI
    Anesth Analg; 2021 Jun; 132(6):1666-1676. PubMed ID: 34032663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversibility of Rocuronium-Induced Deep Neuromuscular Block with Sugammadex in Infants and Children-A Randomized Study.
    Matsui M; Konishi J; Suzuki T; Sekijima C; Miyazawa N; Yamamoto S
    Biol Pharm Bull; 2019 Oct; 42(10):1637-1640. PubMed ID: 31406051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of recovery times from rocuronium-induced muscle relaxation after reversal with three different doses of sugammadex and succinylcholine during electroconvulsive therapy.
    Kadoi Y; Hoshi H; Nishida A; Saito S
    J Anesth; 2011 Dec; 25(6):855-9. PubMed ID: 21947754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery: under inhaled vs. intravenous anesthesia].
    Veiga-Ruiz G; Domínguez N; Orozco J; Janda M; Hofmockel R; Alvarez-Gómez JA
    Rev Esp Anestesiol Reanim; 2009; 56(6):349-54. PubMed ID: 19725342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
    Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
    Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual paralysis caused by 50 mg rocuronium after reversal with 4 mg/kg sugammadex: a case report.
    Uzawa K; Seki H; Yorozu T
    BMC Anesthesiol; 2021 May; 21(1):154. PubMed ID: 34016059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
    de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
    Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A temporary decrease in twitch response during reversal of rocuronium-induced muscle relaxation with a small dose of sugammadex.
    Eleveld DJ; Kuizenga K; Proost JH; Wierda JM
    Anesth Analg; 2007 Mar; 104(3):582-4. PubMed ID: 17312212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of age on sugammadex reversal of neuromuscular blockade induced by rocuronium in Chinese children: a prospective pilot trial.
    Zhang R; Hu J; Li S; Xue B; Wang L; Bai J; Zheng J
    BMC Anesthesiol; 2021 Oct; 21(1):248. PubMed ID: 34666673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
    Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
    Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences of Recovery from Rocuronium-induced Deep Paralysis in Response to Small Doses of Sugammadex between Elderly and Nonelderly Patients.
    Muramatsu T; Isono S; Ishikawa T; Nozaki-Taguchi N; Okazaki J; Kitamura Y; Murakami N; Sato Y
    Anesthesiology; 2018 Nov; 129(5):901-911. PubMed ID: 30199419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of protracted dexamethasone exposure and its withdrawal on rocuronium-induced neuromuscular blockade and sugammadex reversal: an ex vivo rat study.
    Oh SK; Lim BG; Park S; Yang HS; In J; Kim YB; Choi HR; Lee IO
    Sci Rep; 2019 Aug; 9(1):11268. PubMed ID: 31375743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.